SCHEMBL2910075

SCHEMBL2910075

C[C@H](O)CNC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1cccc(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
GSK3B P49841 5/20 0.39
GSK3A P49840 4/20 0.39
CDK1 P06493 2/20 0.36
CCNB2 O95067 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
LMNA P02545 2/20 0.35
PTGS2 P35354 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
FOLH1 Q04609 1/20 0.33
POLB P06746 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CYP2C19 P33261 2/20 0.33
DCAF1 Q9Y4B6 1/20 0.33
MAPT P10636 2/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912143 1.00 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2904193 0.91 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2912251 0.91 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2909835 0.89 GSK3B (0.48) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2912195 0.89 GSK3B (0.48) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2911799 0.88 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2934514 0.88 GSK3B (0.47) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2904498 0.88 GSK3B (0.47) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2910313 0.88 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1
SCHEMBL2907739 0.88 GSK3B (0.42) SMN1; SMN2ALDH1A1GSK3BGSK3ACDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed